Our Team Visits Key Clients in South Korea, Including Leading Pharma Innovator Dong-A Pharm
In May 2025, our team embarked on a business trip to South Korea to meet with several of our valued partners, including Dong-A Pharm — the country's foremost pharmaceutical research and development company.
Meeting Key Partners in Seoul
During the visit, we engaged in productive discussions with Dong-A Pharm's leadership and R&D teams, exploring ways to deepen our collaboration. As a pioneer in drug development and innovation, Dong-A Pharm plays a critical role in advancing healthcare solutions, and we are honored to contribute to their success as a trusted medical device partner.
Deepening Collaboration with Dong-A Pharm
The trip also included meetings with other key clients across the pharmaceutical and healthcare sectors, reinforcing our commitment to delivering excellence and fostering long-term partnerships in the South Korean market. Korea's advanced healthcare ecosystem and stringent regulatory environment demand the highest standards — a challenge our CE MDR and ISO 13485 certified portfolio is well-equipped to meet.
We look forward to continuing our collaboration with Dong-A Pharm and other industry leaders to drive innovation and create impactful solutions for global healthcare challenges.
Interested in our products? Contact our team →